Your browser doesn't support javascript.
loading
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.
Savoldi, Alessia; Morra, Matteo; De Nardo, Pasquale; Cattelan, Anna Maria; Mirandola, Massimo; Manfrin, Vinicio; Scotton, Piergiorgio; Giordani, Maria Teresa; Brollo, Lucio; Panese, Sandro; Lanzafame, Massimiliano; Scroccaro, Giovanna; Berkell, Matilda; Lippi, Giuseppe; Konnova, Angelina; Smet, Mathias; Malhotra-Kumar, Surbhi; Kumar-Singh, Samir; Tacconelli, Evelina.
Afiliação
  • Savoldi A; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.
  • Morra M; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.
  • De Nardo P; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy. pasquale.denardo@univr.it.
  • Cattelan AM; Infectious Disease Unit, Hospital of Padua, Via Giustiniani 2, 35128, Padua, Italy.
  • Mirandola M; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.
  • Manfrin V; School of Health Sciences, University of Brighton, Brighton, UK.
  • Scotton P; Division of Infectious and Tropical Diseases, S. Bortolo Hospital, Viale Ferdinando Rodolfi 37, 36100, Vicenza, Italy.
  • Giordani MT; Infectious Diseases Unit, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.
  • Brollo L; Infectious Diseases Unit, Alto Vicentino Santorso Hospital, Azienda ULSS 7via Garziere 42, Santorso, Vicenza, Italy.
  • Panese S; Division of Internal Medicine and Cardiology, Infectious Diseases and COVID-19 Section, Jesolo Hospital Via Levantina, 104, 30016, Jesolo, Italy.
  • Lanzafame M; Infectious Diseases Unit, Azienda ULSS 3 Serenissima, Ss. Giovanni E Paolo Hospital, Castello 6777, 30122, Venice, Italy.
  • Scroccaro G; Division of Infectious Diseases, Ospedale Santa Maria Della Misericordia Hospital, Viale Tre Martiri 140, Rovigo, Rovigo, Italy.
  • Berkell M; Department of Pharmaceutical and Devices, Venice, Veneto Region, Italy.
  • Lippi G; Lab of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Konnova A; Molecular Pathology Group, Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Smet M; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
  • Malhotra-Kumar S; Molecular Pathology Group, Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Kumar-Singh S; Lab of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Tacconelli E; Lab of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Eur J Clin Microbiol Infect Dis ; 41(7): 1065-1076, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35727429
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article